These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8880665)

  • 1. Does HIV test result influence methadone maintenance treatment retention?
    Wimbush J; Amicarelli A; Stein MD
    J Subst Abuse; 1996; 8(2):263-9. PubMed ID: 8880665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact on behavior of notifying methadone patients of their HIV serostatus.
    Katz SM; Galanter M; Lifshutz H; Maslansky R
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):37-45. PubMed ID: 7762543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of an AIDS prevention program for methadone patients.
    Magura S; Siddiqi Q; Shapiro J; Grossman JI; Lipton DS; Marion IJ; Weisenfeld L; Amann KR; Koger J
    Int J Addict; 1991 Jun; 26(6):629-55. PubMed ID: 1757169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.
    Silberstein CH; O'Dowd MA; Chartock P; Schoenbaum EE; Friedland G; Hartel D; McKegney FP
    Gen Hosp Psychiatry; 1993 Nov; 15(6):351-9. PubMed ID: 8112557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of retention on the South Australian Methadone Program 1981-91.
    Gaughwin M; Solomon P; Ali R
    Aust N Z J Public Health; 1998 Dec; 22(7):771-6. PubMed ID: 9889441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of methadone patients to HIV antibody testing.
    Magura S; Shapiro JL; Grossman JI; Siddiqi Q; Lipton DS; Amann KR; Koger J; Gehan K
    Adv Alcohol Subst Abuse; 1990; 8(3-4):97-111. PubMed ID: 2343800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of preventive health services by HIV-seronegative injection drug users.
    McGarry KA; Stein MD; Clarke JG; Friedmann PD
    J Addict Dis; 2002; 21(2):93-102. PubMed ID: 11916375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.
    Selwyn PA; Budner NS; Wasserman WC; Arno PS
    Public Health Rep; 1993; 108(4):492-500. PubMed ID: 8393579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV antibody testing and client retention in the therapeutic community. A preliminary report of Phoenix House.
    Gonzalez I; Rosenthal MS; Bigler MO; Alper K; Geringer W
    J Subst Abuse Treat; 1994; 11(5):481-8. PubMed ID: 7869470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric symptoms in HIV test consenters and refusers.
    Woody G; Metzger DS; McLellan AT; O'Brien CP; DiPhilipis D
    NIDA Res Monogr; 1989; 95():415-6. PubMed ID: 2641015
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in an outreach-based coupon distribution program for free methadone detoxification.
    Bux DA; Iguchi MY; Lidz V; Baxter RC; Platt JJ
    Hosp Community Psychiatry; 1993 Nov; 44(11):1066-72. PubMed ID: 8288175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of high-risk behavior by HIV-positive drug users. Treatment implications.
    Avants SK; Warburton LA; Hawkins KA; Margolin A
    J Subst Abuse Treat; 2000 Jul; 19(1):15-22. PubMed ID: 10867296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in methadone treatment: the influence of reference groups.
    Hunt DE; Lipton DS; Goldsmith DS; Strug DL
    NIDA Res Monogr; 1984; 46():8-22. PubMed ID: 6427626
    [No Abstract]   [Full Text] [Related]  

  • 17. Retention in a low-threshold methadone maintenance program.
    Torrens M; Castillo C; Pérez-Solá V
    Drug Alcohol Depend; 1996 May; 41(1):55-9. PubMed ID: 8793310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.
    Shah NG; Celentano DD; Vlahov D; Stambolis V; Johnson L; Nelson KE; Strathdee SA
    AIDS; 2000 Sep; 14(13):2035-43. PubMed ID: 10997409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study.
    Weddington WW; Haertzen CA; Hess JM; Brown BS
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):355-68. PubMed ID: 1928028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative program for methadone maintenance dropouts: description and preliminary data.
    Goldstein MF; Deren S; Beardsley M; Richman BL
    Mt Sinai J Med; 2001 Jan; 68(1):33-40. PubMed ID: 11135504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.